drugset / Trial / NCT07606391

Polidocanol 1% and Steroid in Keloids and Hypertrophic Scars

NCT07606391

Not yet recruiting 90 enrolled Sohag University
RandomizedParallel-groupSingle-blindTreatment

Summary

we will inject intralesional polidocanol 1% in keloids and hypertrophic scars to decrease vascularity and decrease size of lesion compared to intralesional steroid as standard treatment line

Timeline

Start
2026-08-01
Primary completion
2026-08-01
Completion
2027-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polidocanol Other / unclassified 1 % Other
Comparator Polidocanol Other / unclassified 1 ml Other
Comparator Triamcinolone Acetonide Other / unclassified 1 ml Other
Comparator Triamcinolone Acetonide Other / unclassified 20 mg/ml Other